BRIEF published on 05/07/2024 at 20:31, 2 years 3 months ago Biotest AG: Dividend Approval at Annual General Meeting Annual General Meeting Shareholder Approval Dividend Distribution Preference Shares Biotest AG
BRIEF published on 05/07/2024 at 20:31, 2 years 3 months ago Biotest AG : approbation du dividende lors de l'assemblée générale annuelle Assemblée Générale Annuelle Approbation Des Actionnaires Répartition Des Dividendes Partage De Préférence Biotest SA
PRESS RELEASE published on 05/07/2024 at 20:26, 2 years 3 months ago Biotest AG: Annual General Meeting approves dividend distribution Biotest AG's Annual General Meeting approves dividend distribution of EUR 0.04 per preference share for 2023 and 2022, with majority support. CEO Peter Janssen's speech available online Annual General Meeting Shareholders Dividend Distribution Biotest AG Peter Janssen
BRIEF published on 05/07/2024 at 09:05, 2 years 3 months ago Biotest AG Reports Significant Growth in Q1 2024 Revenue Growth Biotest AG Yimmugo Q1 2024 Financial Results Plasma Products
BRIEF published on 05/07/2024 at 09:05, 2 years 3 months ago Biotest AG annonce une croissance significative au premier trimestre 2024 Hausse Des Revenus Yimmugo Biotest SA Résultats Financiers Du Premier Trimestre 2024 Produits Plasmatiques
PRESS RELEASE published on 05/07/2024 at 09:00, 2 years 3 months ago Biotest increased sales by 83.6% to Euro 215.2 million in first quarter 2024 Biotest AG reports a significant 83.6% increase in sales to Euro 215.2 million in the first quarter of 2024, driven by product sales and successful completion of the Fibrinogen study EBIT Sales Increase Biotest AG First Quarter 2024 Fibrinogen Study
BRIEF published on 04/19/2024 at 09:05, 2 years 4 months ago Biotest AG Launches 12th Plasma Collection Centre in Germany Healthcare Biotest AG Plasma Donation Plasma Collection Centre Wuppertal
BRIEF published on 04/19/2024 at 09:05, 2 years 4 months ago Biotest AG lance le 12ème centre de collecte de plasma en Allemagne Soins De Santé Don De Plasma Biotest SA Wuppertal Centre De Collecte De Plasma
PRESS RELEASE published on 04/19/2024 at 09:00, 2 years 4 months ago Biotest AG opens 12th plasma collection centre in Germany Biotest AG opens 12th plasma collection centre in Germany, expanding its presence in Europe to ensure a stable plasma supply. The new centre in Wuppertal offers convenient donation options for locals Europe Germany Biotest AG Plasma Donation Plasma Collection Centre
BRIEF published on 03/28/2024 at 12:43, 2 years 5 months ago Biotest AG Reports 32% Sales Growth for Fiscal Year 2023 Financial Results Biotest AG Yimmugo Fibrinogen Study Grifols Partnership
Published on 08/29/2026 at 05:15, 1 day 15 hours ago Norsemont Announces Restatement of Financial Statements
Published on 08/29/2026 at 03:20, 1 day 16 hours ago BEACN Announces Financial Results for the Second Quarter of 2026
Published on 08/29/2026 at 01:15, 1 day 19 hours ago Gamma Resources Announces Increase in Private Placement to $1,750,000 and Closing of First Tranche at $872,500
Published on 08/29/2026 at 01:00, 1 day 19 hours ago Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
Published on 08/28/2026 at 23:00, 1 day 21 hours ago Guanajuato Silver Grants Stock Options to Officer
Published on 08/29/2026 at 04:05, 1 day 16 hours ago INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces
Published on 08/28/2026 at 20:49, 1 day 23 hours ago Publication pursuant to Article 5(1)(b) and (3) of Regulation (EU) No. 596/2014 and Article 2(2) and (3) of the Commission Delegated Regulation (EU) No. 2016/1052 - Final Announcement
Published on 08/28/2026 at 20:42, 1 day 23 hours ago Aroundtown SA: Release of a capital market information
Published on 08/28/2026 at 19:10, 2 days 1 hour ago Invitation to Professional or Qualified Investors holding Notes to submit offers for Branicks Bridge Notes and VIB Bridge Notes
Published on 08/28/2026 at 18:01, 2 days 2 hours ago CPI Europe announces unaudited results for the first half of 2026
